The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from in silico to in vivo

Dipeptidyl peptidase IV (DPP-4), an incretin glucagon-like peptide-1 (GLP-1) degrading enzyme, contains two forms and it can exert various physiological functions particular in controlling blood glucose through the action of GLP-1. In diabetic use, the DPP-4 inhibitor can block the DDP-4 to attenuat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shian-Ren, Chang, Chia-Hsiang, Tsai, May-Jwan, Cheng, Henrich, Chen, Jian-Chyi, Leong, Max K., Weng, Ching-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753520/
https://www.ncbi.nlm.nih.gov/pubmed/31555430
http://dx.doi.org/10.1177/2040622319875305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753520/
https://www.ncbi.nlm.nih.gov/pubmed/31555430
http://dx.doi.org/10.1177/2040622319875305

Ejemplares similares